Cargando…

Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis

Purpose. To demonstrate the long-term effectiveness of vitrectomy for intermediate uveitis (IU) and to determine whether complete control of inflammation before vitrectomy is necessary. Methods. This retrospective study included 66 eyes of 66 patients with IU who underwent vitrectomy for vitreoretin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Yong Un, Shin, Joo Young, Ma, Dae Joong, Cho, Heeyoon, Yu, Hyeong Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390648/
https://www.ncbi.nlm.nih.gov/pubmed/28465834
http://dx.doi.org/10.1155/2017/5946240
_version_ 1782521504191217664
author Shin, Yong Un
Shin, Joo Young
Ma, Dae Joong
Cho, Heeyoon
Yu, Hyeong Gon
author_facet Shin, Yong Un
Shin, Joo Young
Ma, Dae Joong
Cho, Heeyoon
Yu, Hyeong Gon
author_sort Shin, Yong Un
collection PubMed
description Purpose. To demonstrate the long-term effectiveness of vitrectomy for intermediate uveitis (IU) and to determine whether complete control of inflammation before vitrectomy is necessary. Methods. This retrospective study included 66 eyes of 66 patients with IU who underwent vitrectomy for vitreoretinal complications. Eyes were followed for at least 12 months after vitrectomy. The degree of inflammation control and visual acuity were compared before and after vitrectomy. These parameters were compared according to the presence of complete inflammation control before surgery. Results. The indications of vitrectomy included epiretinal membrane (26 eyes), vitreous opacity (21 eyes), and tractional retinal detachment (12 eyes), among others. Uveitic attacks did not occur in 44 of the 66 patients after vitrectomy. The numbers of uveitis attacks, local steroid injections, and systemic medications significantly decreased, and vision meaningfully improved after vitrectomy. These parameters did not differ significantly, regardless of the presence of preoperative inflammation. Conclusions. This study showed that vitrectomy is a good modality to manage vitreoretinal complications associated with IU, even if complete control of intraocular inflammation is not achieved before vitrectomy.
format Online
Article
Text
id pubmed-5390648
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-53906482017-05-02 Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis Shin, Yong Un Shin, Joo Young Ma, Dae Joong Cho, Heeyoon Yu, Hyeong Gon J Ophthalmol Clinical Study Purpose. To demonstrate the long-term effectiveness of vitrectomy for intermediate uveitis (IU) and to determine whether complete control of inflammation before vitrectomy is necessary. Methods. This retrospective study included 66 eyes of 66 patients with IU who underwent vitrectomy for vitreoretinal complications. Eyes were followed for at least 12 months after vitrectomy. The degree of inflammation control and visual acuity were compared before and after vitrectomy. These parameters were compared according to the presence of complete inflammation control before surgery. Results. The indications of vitrectomy included epiretinal membrane (26 eyes), vitreous opacity (21 eyes), and tractional retinal detachment (12 eyes), among others. Uveitic attacks did not occur in 44 of the 66 patients after vitrectomy. The numbers of uveitis attacks, local steroid injections, and systemic medications significantly decreased, and vision meaningfully improved after vitrectomy. These parameters did not differ significantly, regardless of the presence of preoperative inflammation. Conclusions. This study showed that vitrectomy is a good modality to manage vitreoretinal complications associated with IU, even if complete control of intraocular inflammation is not achieved before vitrectomy. Hindawi 2017 2017-03-30 /pmc/articles/PMC5390648/ /pubmed/28465834 http://dx.doi.org/10.1155/2017/5946240 Text en Copyright © 2017 Yong Un Shin et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Shin, Yong Un
Shin, Joo Young
Ma, Dae Joong
Cho, Heeyoon
Yu, Hyeong Gon
Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis
title Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis
title_full Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis
title_fullStr Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis
title_full_unstemmed Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis
title_short Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis
title_sort preoperative inflammatory control and surgical outcome of vitrectomy in intermediate uveitis
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390648/
https://www.ncbi.nlm.nih.gov/pubmed/28465834
http://dx.doi.org/10.1155/2017/5946240
work_keys_str_mv AT shinyongun preoperativeinflammatorycontrolandsurgicaloutcomeofvitrectomyinintermediateuveitis
AT shinjooyoung preoperativeinflammatorycontrolandsurgicaloutcomeofvitrectomyinintermediateuveitis
AT madaejoong preoperativeinflammatorycontrolandsurgicaloutcomeofvitrectomyinintermediateuveitis
AT choheeyoon preoperativeinflammatorycontrolandsurgicaloutcomeofvitrectomyinintermediateuveitis
AT yuhyeonggon preoperativeinflammatorycontrolandsurgicaloutcomeofvitrectomyinintermediateuveitis